Yang S Z, Ji S Q
Department of Internal Medicine, Affiliated Hospital, Nanjing Railway Medical College, China.
Respir Med. 1994 Jan;88(1):27-9. doi: 10.1016/0954-6111(94)90170-8.
The measurement of CA50 in serum and pleural fluid by immunoradiometric assay was presented in 45 (27 malignancy and 18 tuberculosis) patients with pleural effusion. The mean CA50 level in malignant effusion (89.26 +/- 122.32 U ml-1) was significantly higher than that in tuberculous effusion (5.18 +/- 8.65 U ml-1) (P < 0.001). CA50 levels of pleural fluid above an arbitrary level of 20 U ml-1 were found in 78% of malignant fluids and in 6% of tuberculous fluids. The serum CA50 value from 27 patients with malignant effusion (58.67 +/- 85.85 U ml-1) was also higher than that from 18 patients with tuberculous effusion (6.18 +/- 8.37 U ml-1) (P < 0.001). CA50 levels of serum above the same level were found in 58% of patients with malignant fluid and in 6% of patients with tuberculous fluid. The results suggested that the measurement of CA50 in pleural effusion may be helpful in the differential diagnosis between tuberculous and malignant effusions.
采用免疫放射分析法对45例胸腔积液患者(27例恶性肿瘤患者和18例结核患者)的血清和胸液中的CA50进行了检测。恶性胸腔积液中CA50的平均水平(89.26±122.32 U/ml)显著高于结核性胸腔积液(5.18±8.65 U/ml)(P<0.001)。在78%的恶性胸液和6%的结核性胸液中发现胸液CA50水平高于任意设定的20 U/ml水平。27例恶性胸腔积液患者的血清CA50值(58.67±85.85 U/ml)也高于18例结核性胸腔积液患者(6.18±8.37 U/ml)(P<0.001)。在58%的恶性胸液患者和6%的结核性胸液患者中发现血清CA50水平高于同一水平。结果表明,检测胸腔积液中的CA50可能有助于结核性和恶性胸腔积液的鉴别诊断。